Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average: 2011-2025

Historic Assets Average for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to $369.5 million.

  • Ironwood Pharmaceuticals' Assets Average fell 5.88% to $369.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.5 million, marking a year-over-year decrease of 5.88%. This contributed to the annual value of $411.0 million for FY2024, which is 47.70% down from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Assets Average is $369.5 million, which was up 10.27% from $335.1 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Assets Average high stood at $1.1 billion for Q1 2023, and its period low was $335.1 million during Q2 2025.
  • In the last 3 years, Ironwood Pharmaceuticals' Assets Average had a median value of $417.2 million in 2024 and averaged $522.4 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Assets Average soared by 122.96% in 2021 and then slumped by 59.66% in 2024.
  • Ironwood Pharmaceuticals' Assets Average (Quarterly) stood at $1.1 billion in 2021, then declined by 2.97% to $1.1 billion in 2022, then slumped by 53.52% to $497.6 million in 2023, then dropped by 25.60% to $370.2 million in 2024, then decreased by 5.88% to $369.5 million in 2025.
  • Its Assets Average stands at $369.5 million for Q3 2025, versus $335.1 million for Q2 2025 and $339.1 million for Q1 2025.